2 options
Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712).
Connect to full text Available online
View online- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. House. Committee on Energy and Commerce, author.
- Series:
- United States. Congress. House. Report ; 116-572.
- Report / 116th Congress, 2d session, House of Representatives ; 116-572
- Language:
- English
- Subjects (All):
- United States. Food and Drug Administration.
- United States.
- Drug development--Economic aspects--United States.
- Drug development.
- Buprenorphine--Therapeutic use--United States.
- Buprenorphine.
- Orphan drugs--Government policy--United States.
- Orphan drugs.
- Drugs--Prices--Government policy--United States.
- Drugs.
- Drugs--Law and legislation--United States.
- Orphan drugs--United States.
- Rare diseases--United States.
- Rare diseases.
- Buprenorphine--Therapeutic use.
- Drugs--Law and legislation.
- Drugs--Prices--Government policy.
- Orphan drugs--Government policy.
- Genre:
- legislative records.
- Legislative materials
- Legislative materials.
- Physical Description:
- 1 online resource (11 pages).
- Place of Publication:
- [Washington, D.C.] : [U.S. Government Publishing Office], [2020]
- Notes:
- "November 16, 2020."
- Includes bibliographical references.
- Description based on online resource; title from PDF caption (govinfo, viewed Nov. 30, 2020).
- Other Format:
- Print version: United States. Congress. House. Committee on Energy and Commerce. Fairness in Orphan Drug Exclusivity Act
- OCLC:
- 1224541481
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.